Literature DB >> 4204682

Removing substances from blood by affinity chromatography. I. Removing bilirubin and other albumin-bound substances from plasma and blood with albumin-conjugated agarose beads.

P H Plotz, P D Berk, B F Scharschmidt, J K Gordon, J Vergalla.   

Abstract

Substances such as bilirubin that bind tightly to plasma proteins cannot readily be removed from blood. We describe here the use of affinity chromatography as a new approach to the removal of proteinbound metabolites and toxins from blood. Agarose beads were coupled via cyanogen bromide to human serum albumin so as to contain 30-50 mg of albumin/g wet wt. Such beads, when exposed to plasma from a patient with congenital nonhemolytic jaundice labeled with [(14)C]-bilirubin, bound more than 150 mug bilirubin/g of beads. The binding was saturable, concentration-dependent, relatively independent of flow rate, and reversible by elution with plasma, albumin, or 50% (vol/vol) ethanol. The beads could be repeatedly reused without loss of efficiency after ethanol elution and long storage in the cold. Salicylate, cortisol, and taurocholate, which bind weakly to albumin, were retarded by the beads but eluted with neutral buffer. Thyroxine, taurolithocholate, chenodeoxycholate, and digitoxin bound tightly but were eluted with 50% ethanol. Digoxin did not bind at all. When whole blood was passed over agarose-albumin beads, bilirubin was removed, calcium and magnesium fell slightly, but red cells, white cells, platelets, clotting factors, and a variety of electrolytes and proteins were substantially unchanged. Agarose-albumin beads may be useful for removing protein-bound substances from the blood of patients with liver failure, intoxication with protein-bound drugs, or specific metabolic deficits. Furthermore, it may be possible to make useful adsorbents by attaching other proteins to agarose or other polymer beads.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4204682      PMCID: PMC333058          DOI: 10.1172/JCI107616

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Studies in kernicterus. I. The protein binding of bilirubin.

Authors:  G B ODELL
Journal:  J Clin Invest       Date:  1959-05       Impact factor: 14.808

2.  Bile acid content of human serum. II. The binding of cholanic acids by human plasma proteins.

Authors:  D RUDMAN; F E KENDALL
Journal:  J Clin Invest       Date:  1957-04       Impact factor: 14.808

3.  Influence of light on the hyperbilirubinaemia of infants.

Authors:  R J CREMER; P W PERRYMAN; D H RICHARDS
Journal:  Lancet       Date:  1958-05-24       Impact factor: 79.321

4.  Replacement transfusion as a treatment for erythroblastosis fetalis.

Authors:  L K DIAMOND
Journal:  Pediatrics       Date:  1948-11       Impact factor: 7.124

5.  Effect of free fatty acids on binding of drugs by bovine serum albumin, by human serum albumin and by rabbit serum.

Authors:  D Rudman; T J Bixler; A E Del Rio
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

6.  High capacity chemisorbents for protein immobilization.

Authors:  J Porath; L Sundberg
Journal:  Nat New Biol       Date:  1972-08-30

7.  Covalent binding of biomolecules to radiation-grafted hydrogels on inert polymer surfaces.

Authors:  A S Hoffman; G Schmer; C Harris; W G Kraft
Journal:  Trans Am Soc Artif Intern Organs       Date:  1972

8.  Toward an artificial liver: in vitro removal of unbound and protein-bound plasma compounds related to hepatic failure.

Authors:  R A Willson; K H Webster; A F Hofmann; W H Summerskill
Journal:  Gastroenterology       Date:  1972-06       Impact factor: 22.682

9.  Factors influencing toxicity of bilirubin in cerebellum tissue culture.

Authors:  D H Silberberg; L Johnson; L Ritter
Journal:  J Pediatr       Date:  1970-09       Impact factor: 4.406

10.  Removing substances from blood by affinity chromatography. II. Removing bilirubin from the blood of jaundiced rats by hemoperfusion over albumin-conjugated agarose beads.

Authors:  B F Scharschmidt; P H Plotz; P D Berk; J G Waggoner; J Vergalla
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

View more
  4 in total

1.  Editorial: Haemoperfusion for jaundice.

Authors: 
Journal:  Br Med J       Date:  1974-08-24

2.  Phenolsulfonphthalein (phenol red) metabolism in primary monolayer cultures of adult rat hepatocytes.

Authors:  J L Driscoll; N T Hayner; R Williams-Holland; G Spies-Karotkin; P M Galletti; H O Jauregui
Journal:  In Vitro       Date:  1982-10

3.  Removing substances from blood by affinity chromatography. II. Removing bilirubin from the blood of jaundiced rats by hemoperfusion over albumin-conjugated agarose beads.

Authors:  B F Scharschmidt; P H Plotz; P D Berk; J G Waggoner; J Vergalla
Journal:  J Clin Invest       Date:  1974-03       Impact factor: 14.808

4.  Hepatic organic anion uptake in the rat.

Authors:  B F Scharschmidt; J G Waggoner; P D Berk
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.